Search - tctmd.com

Displaying 621 - 639 of 639

Sort: Relevancy | Date

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Industry News

Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Industry News

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

March 28, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Jason Kahn

February 23, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

News Daily News

Steady Decline Seen in PCI Use Over Last Few Years

L.A. McKeown

February 21, 2011

News Daily News

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

February 13, 2011

News Daily News

IVUS Study Investigates Mechanisms of DES Restenosis

Jason Kahn

February 06, 2011

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

News Industry News

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

January 23, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Jason Kahn

January 12, 2011

Partner Content

The Role of IN.PACT™ Admiral™ in the Treatment of Complex Lesions: Medtronic

November 2, 2021

Video

62633

September 27, 2019

Partner Content

XIENCE Safety in the Modern Era

November 7, 2017

Advertisement

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Studies Support DES Use in Diabetics, But Results Vary by Device

Cilostazol Reduces Repeat Revascularizations for Long Lesions

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Paclitaxel-Eluting Balloon Effective for DES Restenosis

Steady Decline Seen in PCI Use Over Last Few Years

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

IVUS Study Investigates Mechanisms of DES Restenosis

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

The Role of IN.PACT™ Admiral™ in the Treatment of Complex Lesions: Medtronic

62633

XIENCE Safety in the Modern Era

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content